dc.creatorSan Martín Núñez, Betty
dc.creatorFresno, Marcela
dc.creatorCornejo, Javiera
dc.creatorGodoy, Marcos
dc.creatorIbarra, Rolando
dc.creatorVidal, Roberto
dc.creatorAraneda, Marcelo
dc.creatorAnadón, Arturo
dc.creatorLapierre Acevedo, Lisette
dc.date.accessioned2019-10-30T15:40:09Z
dc.date.available2019-10-30T15:40:09Z
dc.date.created2019-10-30T15:40:09Z
dc.date.issued2019
dc.identifierPLoS ONE, Volumen 14, Issue 5, 2019,
dc.identifier19326203
dc.identifier10.1371/journal.pone.0215174
dc.identifierhttps://repositorio.uchile.cl/handle/2250/172544
dc.description.abstractSalmonid Rickettsial Septicemia (SRS) is the disease of greatest economic importance in the Chilean salmon farming industry, causing high mortality in fish during the final stage of their productive cycle at sea. Since current, commercially available vaccines have not demonstrated the expected efficacy levels, antimicrobials, most commonly florfenicol, are still the main resource for the treatment and control of this pathogen. The aim of this study was to determine the most appropriate single dose of florfenicol, administered through medicated feed, for the treatment of Piscirickettsia salmonis (P. salmonis), using pharmacokinetic/pharmacodynamic (PK/PD) models. Previously, Minimum Inhibitory Concentrations (MICs) of florfenicol were determined for 87 P. salmonis isolates in order to define the epidemiological cut-off point (COWT). The most commonly observed MIC was 0.125 μg mL-1 (83.7%). The COWT value was 0.25 μg mL-1 with a standard deviation of 0.47 log2 μg mL-1 and 0.36 log2 μg mL-1, for Normalized resistance interpretation (NRI) method and ECOFFinder method, respectively. A MIC of 1 μg mL-1 was considered the pharmacodynamic value (PD) to define PK/PD indices. Three doses of florfenicol were evaluated in fish farmed under controlled conditions. For each dose, 150 fish were used and blood plasma samples were collected at different time points (0–48 hours). PK parameters were obtained from curves representing plasma concentrations as a function of time. The results of Monte Carlo simulation indicate that at a dose of 20 mg/Kg l.w. of florfenicol, administered orally as medicated feed, there is 100% probability (PTA) of achieving the desired efficacy (AUC0-24h/MIC>125). According to these results, we suggest that at the indicated dose, the PK/PD cut-off point for florfenicol versus P. salmonis could be 2 μg mL-1 (PTA = 99%). In order to assess the indicated dose in Atlantic salmon, fish were inoculated with P. salmonis LF-89 strain and then treated with the optimized dose of florfenicol, 20 mg/Kg bw for 15 days.
dc.languageen
dc.publisherPublic Library of Science
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourcePLoS ONE
dc.subjectBiochemistry, Genetics and Molecular Biology (all)
dc.subjectAgricultural and Biological Sciences (all)
dc.titleOptimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución